Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism

Terminal restriction fragment length polymorphism (T-RFLP) was investigated as a tool for monitoring the human intestinal microflora during antibiotic treatment and during ingestion of a probiotic product. Fecal samples from eight healthy volunteers were taken before, during, and after administratio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Applied and environmental microbiology Ročník 71; číslo 1; s. 501
Hlavní autoři: Jernberg, Cecilia, Sullivan, Asa, Edlund, Charlotta, Jansson, Janet K
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.01.2005
Témata:
Anti-Bacterial Agents - pharmacology
Bacteria - classification
Bacteria - genetics
Bacteria - growth & development
Bacteria - isolation & purification
Clindamycin - pharmacology
Colony Count, Microbial
DNA Fingerprinting - methods
DNA, Bacterial - analysis
Eubacterium - genetics
Eubacterium - isolation & purification
Humans
Intestines - drug effects
Intestines - microbiology
Lactobacillus - genetics
Lactobacillus - isolation & purification
Polymorphism, Restriction Fragment Length
Probiotics
ISSN:0099-2240
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Terminal restriction fragment length polymorphism (T-RFLP) was investigated as a tool for monitoring the human intestinal microflora during antibiotic treatment and during ingestion of a probiotic product. Fecal samples from eight healthy volunteers were taken before, during, and after administration of clindamycin. During treatment, four subjects were given a probiotic, and four subjects were given a placebo. Changes in the microbial intestinal community composition and relative abundance of specific microbial populations in each subject were monitored by using viable counts and T-RFLP fingerprints. T-RFLP was also used to monitor specific bacterial populations that were either positively or negatively affected by clindamycin. Some dominant bacterial groups, such as Eubacterium spp., were easily monitored by T-RFLP, while they were hard to recover by cultivation. Furthermore, the two probiotic Lactobacillus strains were easily tracked by T-RFLP and were shown to be the dominant Lactobacillus community members in the intestinal microflora of subjects who received the probiotic.
AbstractList Terminal restriction fragment length polymorphism (T-RFLP) was investigated as a tool for monitoring the human intestinal microflora during antibiotic treatment and during ingestion of a probiotic product. Fecal samples from eight healthy volunteers were taken before, during, and after administration of clindamycin. During treatment, four subjects were given a probiotic, and four subjects were given a placebo. Changes in the microbial intestinal community composition and relative abundance of specific microbial populations in each subject were monitored by using viable counts and T-RFLP fingerprints. T-RFLP was also used to monitor specific bacterial populations that were either positively or negatively affected by clindamycin. Some dominant bacterial groups, such as Eubacterium spp., were easily monitored by T-RFLP, while they were hard to recover by cultivation. Furthermore, the two probiotic Lactobacillus strains were easily tracked by T-RFLP and were shown to be the dominant Lactobacillus community members in the intestinal microflora of subjects who received the probiotic.Terminal restriction fragment length polymorphism (T-RFLP) was investigated as a tool for monitoring the human intestinal microflora during antibiotic treatment and during ingestion of a probiotic product. Fecal samples from eight healthy volunteers were taken before, during, and after administration of clindamycin. During treatment, four subjects were given a probiotic, and four subjects were given a placebo. Changes in the microbial intestinal community composition and relative abundance of specific microbial populations in each subject were monitored by using viable counts and T-RFLP fingerprints. T-RFLP was also used to monitor specific bacterial populations that were either positively or negatively affected by clindamycin. Some dominant bacterial groups, such as Eubacterium spp., were easily monitored by T-RFLP, while they were hard to recover by cultivation. Furthermore, the two probiotic Lactobacillus strains were easily tracked by T-RFLP and were shown to be the dominant Lactobacillus community members in the intestinal microflora of subjects who received the probiotic.
Terminal restriction fragment length polymorphism (T-RFLP) was investigated as a tool for monitoring the human intestinal microflora during antibiotic treatment and during ingestion of a probiotic product. Fecal samples from eight healthy volunteers were taken before, during, and after administration of clindamycin. During treatment, four subjects were given a probiotic, and four subjects were given a placebo. Changes in the microbial intestinal community composition and relative abundance of specific microbial populations in each subject were monitored by using viable counts and T-RFLP fingerprints. T-RFLP was also used to monitor specific bacterial populations that were either positively or negatively affected by clindamycin. Some dominant bacterial groups, such as Eubacterium spp., were easily monitored by T-RFLP, while they were hard to recover by cultivation. Furthermore, the two probiotic Lactobacillus strains were easily tracked by T-RFLP and were shown to be the dominant Lactobacillus community members in the intestinal microflora of subjects who received the probiotic.
Author Edlund, Charlotta
Jernberg, Cecilia
Sullivan, Asa
Jansson, Janet K
Author_xml – sequence: 1
  givenname: Cecilia
  surname: Jernberg
  fullname: Jernberg, Cecilia
  organization: Section for Natural Sciences, Södertörn University College, Huddinge, Sweden
– sequence: 2
  givenname: Asa
  surname: Sullivan
  fullname: Sullivan, Asa
– sequence: 3
  givenname: Charlotta
  surname: Edlund
  fullname: Edlund, Charlotta
– sequence: 4
  givenname: Janet K
  surname: Jansson
  fullname: Jansson, Janet K
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15640226$$D View this record in MEDLINE/PubMed
BookMark eNo1kM1OwzAQhH0oglJ4BJBP3BI2rmOSY1WVHwnEpffKsTetUWwX2zn0pXhGXFpOq9HOfBrNNZk475CQuwrKqmLN42L1UT5VZVXWUBU1iJIB1BMyBWjbgjEOV-Q6xi8A4CCaS3JV1YIDY2JKfj68M8kH47bU91S6ZDrjk1GFcXpUqKkcEgaZjHeRGkfTDulutNJlkTAm4-RArVHB94MPMhM01ZhQHRNH5D74E5HGFKTJlO5Ax4jHXybbP0DIpGBOmT7IrUWX6IBum3Z074eD9WG_M9HekIteDhFvz3dG1s-r9fK1eP98eVsu3gslmjYVuu61kBIll6wBzQWvBGJTd62ooVXNvFO8ZxwZY0pJ1gFCO89u6ETWms3Iwwmby3-PudvGmqhwGKRDP8aNeJpzUeftZ-T-bBw7i3qzD8bKcNj8D8x-AWZOhNQ
CitedBy_id crossref_primary_10_1177_08971900241248883
crossref_primary_10_1007_s00248_006_9199_5
crossref_primary_10_1016_j_pharmthera_2023_108442
crossref_primary_10_1155_2008_597603
crossref_primary_10_1186_s12887_022_03633_3
crossref_primary_10_1007_s12035_023_03326_7
crossref_primary_10_4308_hjb_20_2_57
crossref_primary_10_1371_journal_pone_0008584
crossref_primary_10_1007_s00203_010_0654_9
crossref_primary_10_1111_j_1753_4887_2012_00493_x
crossref_primary_10_1017_S0950268813001362
crossref_primary_10_1038_ismej_2007_3
crossref_primary_10_1111_nmo_12340
crossref_primary_10_1016_j_chemosphere_2017_08_064
crossref_primary_10_1128_AEM_02223_06
crossref_primary_10_1128_AEM_00514_08
crossref_primary_10_1099_jmm_0_47615_0
crossref_primary_10_1172_JCI72333
crossref_primary_10_3390_ijerph19095701
crossref_primary_10_1007_BF03175569
crossref_primary_10_1111_j_1365_2672_2009_04602_x
crossref_primary_10_1108_BFJ_06_2011_0163
crossref_primary_10_1038_nature06245
crossref_primary_10_1016_j_anifeedsci_2011_04_005
crossref_primary_10_1016_j_fmrre_2005_04_009
crossref_primary_10_1016_j_scitotenv_2019_135674
crossref_primary_10_1111_j_1574_6941_2006_00112_x
crossref_primary_10_1093_femsec_fiw230
crossref_primary_10_1099_jmm_0_47387_0
crossref_primary_10_1128_spectrum_01960_21
crossref_primary_10_3389_fnut_2018_00023
crossref_primary_10_1136_bmjopen_2014_005047
crossref_primary_10_1016_j_jinf_2019_10_008
crossref_primary_10_1007_s12275_010_0126_6
crossref_primary_10_1080_08910600601056699
crossref_primary_10_1016_j_mimet_2012_12_011
crossref_primary_10_1371_journal_pone_0299749
crossref_primary_10_1177_0897190013499527
crossref_primary_10_1016_j_ijantimicag_2006_09_020
crossref_primary_10_1016_j_clim_2010_05_004
crossref_primary_10_1097_MCG_0b013e3181c87e02
crossref_primary_10_1128_AEM_00233_06
crossref_primary_10_1111_j_1348_0421_2009_00140_x
crossref_primary_10_1016_j_mimet_2007_10_011
crossref_primary_10_17221_1012_PSE
crossref_primary_10_1016_j_vetmic_2007_09_012
crossref_primary_10_1021_es201118r
crossref_primary_10_1080_00365540802651897
crossref_primary_10_1016_j_ijfoodmicro_2009_01_011
crossref_primary_10_1016_j_mimet_2006_02_011
crossref_primary_10_1186_1757_4749_5_32
crossref_primary_10_1016_j_watres_2011_09_002
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1128/AEM.71.1.501-506.2005
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Economics
Engineering
Biology
ExternalDocumentID 15640226
Genre Evaluation Studies
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
23M
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
85S
AAZTW
ABOGM
ABPPZ
ABTAH
ACBTR
ACGFO
ACIWK
ACNCT
ACPRK
ADBBV
ADUKH
AENEX
AFFNX
AFRAH
AGCDD
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BKOMP
BTFSW
C1A
CGR
CS3
CUY
CVF
D0L
DIK
E.-
E3Z
EBS
ECM
EIF
EJD
F5P
GX1
H13
HYE
HZ~
H~9
K-O
KQ8
L7B
MVM
NEJ
NPM
O9-
OHT
OK1
P2P
PKN
PQQKQ
RHF
RHI
RNS
RPM
RSF
RXW
TAE
TAF
TN5
TR2
TWZ
UCJ
UHB
VH1
W8F
WH7
WHG
WOQ
X6Y
X7M
XJT
YV5
Z5M
ZCG
ZGI
ZXP
ZY4
~02
~KM
7X8
AAGFI
ADXHL
ID FETCH-LOGICAL-c689t-d5fd6aaea4a280d46416ee85b96509c83bc4f24e222cca2b0e093ea40b6ccad2
IEDL.DBID 7X8
ISICitedReferencesCount 63
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000226458800062&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0099-2240
IngestDate Thu Sep 04 18:17:16 EDT 2025
Wed Feb 19 01:37:37 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c689t-d5fd6aaea4a280d46416ee85b96509c83bc4f24e222cca2b0e093ea40b6ccad2
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://aem.asm.org/content/aem/71/1/501.full.pdf
PMID 15640226
PQID 67346511
PQPubID 23479
ParticipantIDs proquest_miscellaneous_67346511
pubmed_primary_15640226
PublicationCentury 2000
PublicationDate 2005-Jan
20050101
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – month: 01
  year: 2005
  text: 2005-Jan
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Applied and environmental microbiology
PublicationTitleAlternate Appl Environ Microbiol
PublicationYear 2005
References 10568840 - FEMS Microbiol Ecol. 1999 Dec 1;30(4):313-326
12732422 - J Microbiol Methods. 2003 Jul;54(1):57-74
12782380 - J Microbiol Methods. 2003 Aug;54(2):249-56
12865387 - J Antimicrob Chemother. 2003 Aug;52(2):308-11
10788370 - Appl Environ Microbiol. 2000 May;66(5):1980-6
10716083 - Scand J Infect Dis. 2000;32(1):81-5
10831441 - Appl Environ Microbiol. 2000 Jun;66(6):2578-88
10543789 - Appl Environ Microbiol. 1999 Nov;65(11):4799-807
10427043 - Appl Environ Microbiol. 1999 Aug;65(8):3518-25
12680716 - Microbiol Immunol. 2003;47(2):133-42
10721914 - J Nutr. 2000 Feb;130(2S Suppl):396S-402S
3146551 - Infection. 1988;16(6):329-36
9758810 - Appl Environ Microbiol. 1998 Oct;64(10):3854-9
12597356 - Microbiol Immunol. 2002;46(12):819-31
10592216 - Nucleic Acids Res. 2000 Jan 1;28(1):173-4
12732520 - Appl Environ Microbiol. 2003 May;69(5):2548-54
7487040 - Appl Environ Microbiol. 1995 Aug;61(8):3069-75
15066805 - Appl Environ Microbiol. 2004 Apr;70(4):2129-36
11772617 - Appl Environ Microbiol. 2002 Jan;68(1):114-23
19709298 - FEMS Microbiol Ecol. 2002 Dec 1;42(3):387-97
1987160 - J Bacteriol. 1991 Jan;173(2):697-703
11871461 - Lancet Infect Dis. 2001 Sep;1(2):101-14
11282651 - Appl Environ Microbiol. 2001 Apr;67(4):1935-9
12570667 - Curr Pharm Des. 2003;9(2):175-91
7683183 - Appl Environ Microbiol. 1993 Mar;59(3):695-700
19719582 - FEMS Microbiol Ecol. 2003 Oct 1;46(1):53-62
10532383 - Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):265-78
References_xml – reference: 7683183 - Appl Environ Microbiol. 1993 Mar;59(3):695-700
– reference: 12732520 - Appl Environ Microbiol. 2003 May;69(5):2548-54
– reference: 19709298 - FEMS Microbiol Ecol. 2002 Dec 1;42(3):387-97
– reference: 12597356 - Microbiol Immunol. 2002;46(12):819-31
– reference: 10592216 - Nucleic Acids Res. 2000 Jan 1;28(1):173-4
– reference: 10568840 - FEMS Microbiol Ecol. 1999 Dec 1;30(4):313-326
– reference: 12865387 - J Antimicrob Chemother. 2003 Aug;52(2):308-11
– reference: 11282651 - Appl Environ Microbiol. 2001 Apr;67(4):1935-9
– reference: 10427043 - Appl Environ Microbiol. 1999 Aug;65(8):3518-25
– reference: 12570667 - Curr Pharm Des. 2003;9(2):175-91
– reference: 10831441 - Appl Environ Microbiol. 2000 Jun;66(6):2578-88
– reference: 12732422 - J Microbiol Methods. 2003 Jul;54(1):57-74
– reference: 11772617 - Appl Environ Microbiol. 2002 Jan;68(1):114-23
– reference: 10716083 - Scand J Infect Dis. 2000;32(1):81-5
– reference: 3146551 - Infection. 1988;16(6):329-36
– reference: 19719582 - FEMS Microbiol Ecol. 2003 Oct 1;46(1):53-62
– reference: 11871461 - Lancet Infect Dis. 2001 Sep;1(2):101-14
– reference: 12680716 - Microbiol Immunol. 2003;47(2):133-42
– reference: 10532383 - Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):265-78
– reference: 10721914 - J Nutr. 2000 Feb;130(2S Suppl):396S-402S
– reference: 1987160 - J Bacteriol. 1991 Jan;173(2):697-703
– reference: 15066805 - Appl Environ Microbiol. 2004 Apr;70(4):2129-36
– reference: 12782380 - J Microbiol Methods. 2003 Aug;54(2):249-56
– reference: 9758810 - Appl Environ Microbiol. 1998 Oct;64(10):3854-9
– reference: 7487040 - Appl Environ Microbiol. 1995 Aug;61(8):3069-75
– reference: 10788370 - Appl Environ Microbiol. 2000 May;66(5):1980-6
– reference: 10543789 - Appl Environ Microbiol. 1999 Nov;65(11):4799-807
SSID ssj0004068
Score 2.0822651
Snippet Terminal restriction fragment length polymorphism (T-RFLP) was investigated as a tool for monitoring the human intestinal microflora during antibiotic...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 501
SubjectTerms Anti-Bacterial Agents - pharmacology
Bacteria - classification
Bacteria - genetics
Bacteria - growth & development
Bacteria - isolation & purification
Clindamycin - pharmacology
Colony Count, Microbial
DNA Fingerprinting - methods
DNA, Bacterial - analysis
Eubacterium - genetics
Eubacterium - isolation & purification
Humans
Intestines - drug effects
Intestines - microbiology
Lactobacillus - genetics
Lactobacillus - isolation & purification
Polymorphism, Restriction Fragment Length
Probiotics
Title Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism
URI https://www.ncbi.nlm.nih.gov/pubmed/15640226
https://www.proquest.com/docview/67346511
Volume 71
WOSCitedRecordID wos000226458800062&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwEB3xUUR7KGWBQltaH7hmycaO40iVKlSBemHFgcPeVnZsQ6TdZNksSPun-I3MOInEBfXAJZKV2Ini8fh5PH4P4EzxQiZejSKcTXwkFKkBapNFwgptnEqzQuggNpGNx2oyyW824Hd_FobSKnufGBy1rQuKkZ_LjJNs9-jP4iEizSjaW-0ENDZhmyOQIZvOJq-4wmOpeg5Kmri68zvokM8vLq-H2Wg4Gqa4mE7jkKqQvo0xw1xztfe-r_wCnzuMyS5ao9iHDVcNYKdVnVwPYLc_jNwM4NMrPsIDeG5HOBVY7Rn-9NKUNbYS4codbcCysLneBvlYWTFEjyyo_DGinUBvQe-dU46fn6FtYQuWWbcK6V4VNbkItE_YImuCOEXDzJo9No7udXk5M0ZyIcuyreOX-o4CmIwUX1b3bFHP1vMajaNs5odwe3V5-_df1Ak6RIVU-SqyqbdSa6eFTlRshUQ06NAgTE48foXiphA-EQ4xCxpWYmIX5xyfjo3Esk2OYKuqK3cMzMoidd6oNEdAl2Rpbp3yynHBuYtNwk_gV98_UxwvtAmiK1c_NtO-h07ga9vF00VL6zEl2hxENPLbf-t-h4-BwTVEYn7AtkdP4U7hQ_G0Kpvlz2CGeB3fXL8AOwXsRA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Monitoring+of+antibiotic-induced+alterations+in+the+human+intestinal+microflora+and+detection+of+probiotic+strains+by+use+of+terminal+restriction+fragment+length+polymorphism&rft.jtitle=Applied+and+environmental+microbiology&rft.au=Jernberg%2C+Cecilia&rft.au=Sullivan%2C+Asa&rft.au=Edlund%2C+Charlotta&rft.au=Jansson%2C+Janet+K&rft.date=2005-01-01&rft.issn=0099-2240&rft.volume=71&rft.issue=1&rft.spage=501&rft_id=info:doi/10.1128%2FAEM.71.1.501-506.2005&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0099-2240&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0099-2240&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0099-2240&client=summon